Atorvastatin reduces expression of the CCR2 and MAC-1 receptors on monocytes, and plasma levels of monocyte chemoattractant protein-1 and C-reactive protein, in patients with coronary heart disease

  1. Reinares, L.
  2. Figueredo, A.
  3. Rueda, A.
  4. Pontes, J.C.
  5. Rodríguez, A.
  6. Ruiz-Yagüe, M.
  7. Hernández-Presa, M.A.
  8. Pueyo, C.
  9. Hernández, G.
  10. Fernández-Cruz, A.
  11. Patiño, R.
Journal:
Clinical Drug Investigation

ISSN: 1173-2563

Year of publication: 2002

Volume: 22

Issue: 1

Pages: 1-8

Type: Article

DOI: 10.2165/00044011-200222010-00001 GOOGLE SCHOLAR

Sustainable development goals